Market cap When you consider what big pharma spends on research and development how can you not come to the same conclusion as Jeff Nielson
As investors contemplate the addition of Theralase Technologies to their portfolio, here is perhaps the most important number to consider. As TLT moves ever closer to fully proving this amazing anti-cancer technology, the Company is still sitting with a market cap of (as of this writing) only $52 million.
Read more at https://www.stockhouse.com/news/newswire/2018/07/17/refined-anti-cancer-study-yields-breakthrough-result#tTzVPHzmwdPiD2u2.99